Cargando…

Cancer Genome Sequencing and Its Implications for Personalized Cancer Vaccines

New DNA sequencing platforms have revolutionized human genome sequencing. The dramatic advances in genome sequencing technologies predict that the $1,000 genome will become a reality within the next few years. Applied to cancer, the availability of cancer genome sequences permits real-time decision-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Lijin, Goedegebuure, Peter, Mardis, Elaine R., Ellis, Matthew J.C., Zhang, Xiuli, Herndon, John M., Fleming, Timothy P., Carreno, Beatriz M., Hansen, Ted H., Gillanders, William E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763418/ https://www.ncbi.nlm.nih.gov/pubmed/24213133 http://dx.doi.org/10.3390/cancers3044191

Ejemplares similares

Cancer vaccines: shared tumor antigens return to the spotlight
por: Li, Lijin, et al.
Publicado: (2020)

Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation
por: Li, Lijin, et al.
Publicado: (2021)

Mammaglobin-A is a target for breast cancer vaccination
por: Kim, Samuel W., et al.
Publicado: (2016)

Combination TIGIT/PD-1 blockade enhances the efficacy of neoantigen vaccines in a model of pancreatic cancer
por: Peng, Hui, et al.
Publicado: (2022)

Development of an adenovirus vector vaccine platform for targeting dendritic cells
por: Sharma, Piyush K, et al.
Publicado: (2017)

Precision delivery of RAS-inhibiting siRNA to KRAS driven cancer via peptide-based nanoparticles
por: Strand, Matthew S., et al.
Publicado: (2019)

Induction of cancer neoantigens facilitates development of clinically relevant models for the study of pancreatic cancer immunobiology
por: Panni, Usman Y., et al.
Publicado: (2023)

Cancer Genomics
por: Mardis, Elaine
Publicado: (2015)

Cancer-associated mutations reveal a novel role for EpCAM as an inhibitor of cathepsin-L and tumor cell invasion
por: Sankpal, Narendra V., et al.
Publicado: (2021)

The translation of cancer genomics: time for a revolution in clinical cancer care
por: Mardis, Elaine R
Publicado: (2014)

Next-generation cancer genomics
por: Mardis, Elaine R
Publicado: (2010)

Cancer genomics identifies determinants of tumor biology
por: Mardis, Elaine R
Publicado: (2010)

New additions to the cancer precision medicine toolkit
por: Mardis, Elaine R.
Publicado: (2018)

Ten-Patient Trial: Remarkable Responses in Pediatric Cancers
por: Mardis, Elaine R.
Publicado: (2023)

New strategies and emerging technologies for massively parallel sequencing: applications in medical research
por: Mardis, Elaine R
Publicado: (2009)

Incorporation of Porcine Adenovirus 4 Fiber Protein Enhances Infectivity of Adenovirus Vector on Dendritic Cells: Implications for Immune-Mediated Cancer Therapy
por: Wilkinson-Ryan, Ivy, et al.
Publicado: (2015)

Tumor heterogeneity: next-generation sequencing enhances the view from the pathologist’s microscope
por: Aparicio, Samuel, et al.
Publicado: (2014)

Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma
por: Johanns, Tanner M., et al.
Publicado: (2019)

INTEGRATE-neo: a pipeline for personalized gene fusion neoantigen discovery
por: Zhang, Jin, et al.
Publicado: (2017)

pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens
por: Hundal, Jasreet, et al.
Publicado: (2016)

Cancer Genomics: Large-Scale Projects Translate into Therapeutic Advances
por: Mardis, Elaine R., et al.
Publicado: (2016)

Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion
por: Sankpal, Narendra V, et al.
Publicado: (2011)

In Silico Epitope Prediction Analyses Highlight the Potential for Distracting Antigen Immunodominance with Allogeneic Cancer Vaccines
por: James, C. Alston, et al.
Publicado: (2021)

Pediatric cancer: case studies illustrate mechanisms to address significant challenges
por: Kung, Andrew L., et al.
Publicado: (2019)

Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53-deficient mammary cancers
por: Pfefferle, Adam D., et al.
Publicado: (2016)

Translating Human Cancer Sequences Into Personalized Porcine Cancer Models
por: Xu, Chunlong, et al.
Publicado: (2019)

Colon Cancer Biomarkers: Implications for Personalized Medicine
por: Pritzker, Kenneth P.H.
Publicado: (2020)

Anticipating the $1,000 genome
por: Mardis, Elaine R
Publicado: (2006)

The $1,000 genome, the $100,000 analysis?
por: Mardis, Elaine R
Publicado: (2010)

A glimpse at tumor genome evolution
por: Mardis, Elaine R
Publicado: (2011)

California Dreamin': the Future of Genomic Medicine
por: Mardis, Elaine R.
Publicado: (2016)

The challenges of big data
por: Mardis, Elaine R.
Publicado: (2016)

Neoantigens and genome instability: impact on immunogenomic phenotypes and immunotherapy response
por: Mardis, Elaine R.
Publicado: (2019)

Cancer Immunogenomics: Computational Neoantigen Identification and Vaccine Design
por: Hundal, Jasreet, et al.
Publicado: (2017)

Engineering a Novel Modular Adenoviral mRNA Delivery Platform Based on Tag/Catcher Bioconjugation
por: Geng, Kexin, et al.
Publicado: (2023)

Long non-coding RNA RAMS11 promotes metastatic colorectal cancer progression
por: Silva-Fisher, Jessica M., et al.
Publicado: (2020)

Prediction of Cancer Drug Resistance and Implications for Personalized Medicine
por: Volm, Manfred, et al.
Publicado: (2015)

Immunotherapeutic Challenges for Pediatric Cancers
por: Hutzen, Brian, et al.
Publicado: (2019)

Staging of the Axilla in Breast Cancer and the Evolving Role of Axillary Ultrasound
por: Chen, Michael Y, et al.
Publicado: (2021)

Exome sequencing of case-unaffected-parents trios reveals recessive and de novo genetic variants in sporadic ALS
por: Steinberg, Karyn Meltz, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_emjo8n4u18m1m3t00169ngdetg